TSCO
48
3
MO
54
-3
CRM
52
2
BMY
69
6
ADP
65
4
OMC
53
-2
MPC
50
-4
HOG
45
3
VIX
22
-2
SLG
45
-3
EOG
45
3
LUV
71
10
PNR
63
3
BLK
61
6
CME
49
-3
COP
47
2
CMCSA
45
14
NWS
42
-2
O
57
2
BXP
46
-3
TSCO
48
3
MO
54
-3
CRM
52
2
BMY
69
6
ADP
65
4
OMC
53
-2
MPC
50
-4
HOG
45
3
VIX
22
-2
SLG
45
-3
EOG
45
3
LUV
71
10
PNR
63
3
BLK
61
6
CME
49
-3
COP
47
2
CMCSA
45
14
NWS
42
-2
O
57
2
BXP
46
-3
Financhill
Back

Standard BioTools, Inc. 10K Form

Buy
60

LAB
Standard BioTools, Inc.

Last Price:
$1.45
Seasonality Move:
10.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LAB News And Ratings

See the #1 stock for the next 7 days that we like better than LAB

LAB Financial Statistics

Sales & Book Value

Annual Sales: $174.4M
Cash Flow: $-23.1M
Price / Cash Flow: 0
Annual Sales: $1.04
Price / Book: 1.39

Profitability

EPS (TTM): -0.33830
Net Income (TTM): $-109.5M
Gross Margin: $76M
Return on Equity: -24.44%
Return on Assets: -18.43%

Standard BioTools, Inc. Earnings Forecast

Key Standard BioTools, Inc. Financial Ratios

  • The Gross Profit Margin over the past 19 years for LAB is 43.57%.
  • The Selling, General & Administrative Expenses for LAB have been equal to 89.78% of Gross Profit Margin.
  • The Research & Development expenses have been 33.79% of Revenue.
  • The Net Earning history of LAB is -79.62% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 12 years.

Standard BioTools, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: LAB
Website: standardbio.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 4.38
Quick Ratio: 1.93

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 39

LAB Technical Analysis vs Fundamental Analysis

Buy
60
Standard BioTools, Inc. (LAB) is a Buy

Is Standard BioTools, Inc. a Buy or a Sell?